Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Hollander, E.
	Articles by Liebowitz, M. R.
	Search for Related Content



	PubMed Citation
	Articles by Hollander, E.
	Articles by Liebowitz, M. R.

Am J Psychiatry 1988; 145:1015-1017
Copyright © 1988 by American Psychiatric Association

REGULAR ARTICLES

Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings

E Hollander, M Fay, B Cohen, R Campeas, JM Gorman and MR Liebowitz
Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10032.

Six of eight patients with obsessive-compulsive disorder had an exacerbation of symptoms when given m-chlorophenylpiperazine. Fenfluramine and placebo produced mild improvement. Six patients given intravenous clonidine experienced marked reduction in obsessions. Implications for serotonergic and noradrenergic hypotheses of obsessive- compulsive disorder are discussed.

This article has been cited by other articles:

A. Kaplan and E. Hollander
A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder
Focus, July 1, 2004; 2(3): 454 - 461.
[Abstract] [Full Text] [PDF]

A. Kaplan and E. Hollander
A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder
Psychiatr Serv, August 1, 2003; 54(8): 1111 - 1118.
[Abstract] [Full Text] [PDF]

Get information about faster international access.